Skip To Main Content
Kenneth Katende Kidonge on Muck Rack

Kenneth Katende Kidonge

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kenneth Katende

Contact Kenneth Katende, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clients’ perspectives on switching from old stable ART regimens to new dolutegravir-based regimen at joint clinical research centre Uganda

|
By Sarah Nabukeera, Joseph K. B. Matovu, Francis Kanyike, Kenneth Katende Kidonge, John Bosco M. Ddamulira
| Nature Verified
Abstract In 2018, Uganda adopted Dolutegravir (DTG)-based regimens as the preferred first-line antiretroviral therapy (ART). This qualitative study explored the perspectives of people living with HIV (PLHIV) regarding switching from stable ART regimens to DTG at the Joint Clinical Research Centre (JCRC). We purposively sampled 24 participants (16 DTG-experienced, 8 DTG-naïve) and conducted face-to-face in-depth interviews. Data were analysed using inductive thematic analysis.
Open in Who Shared Issue with article?
See all 1 articles